Project Details
Description
A Phase I Platform Study of Rucaparib in Metastatic Castrate-resistant Prostate Cancer: Evaluation of Dose and Safety/tolerability of a Combination of Rucaparib with Androgen Receptor Inhibitors and/or Immunotherapy
| Status | Active |
|---|---|
| Effective start/end date | 9/1/19 → 9/30/24 |
Funding
- CLOVIS ONCOLOGY, INC.
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.